Lee Dobson
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Cystic Fibrosis Research Advances 6
- Occupational and environmental lung diseases 2
- Pleural and Pulmonary Diseases 2
-
- Primary Care and Health Outcomes 4
- Co-authors
- Andrew Tym Hattersley (4 shared papers)Christopher D. Sheldon (4 shared papers)Daryl Paul Wilkerson (1 shared paper)Paul Graham Winyard (1 shared paper)Cathleen S Colon-Emeric (1 shared paper)JAMES A. KELLY (1 shared paper)Mark Gilchrist (1 shared paper)Eleanor Schildwachter McConnell (1 shared paper)
- Journals
- The Lancet (6 papers)International Journal of Technology Assessment in Health Care (2 papers)Nitric Oxide (1 paper)Frontiers in Physiology (1 paper)British Journal of Educational Studies (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Lee Dobson
38 papers receiving 2.2k citations
Lee Dobson's Hit Papers
Peers
Comparison fields: 5 of 123
- Infectious Diseases 966
- Applied Microbiology and Biotechnology 50
- Neurology 348
- Internal Medicine 56
- Pulmonary and Respiratory Medicine 467
Countries citing papers authored by Lee Dobson
This map shows the geographic impact of Lee Dobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Dobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Dobson more than expected).
Fields of papers citing papers by Lee Dobson
This network shows the impact of papers produced by Lee Dobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Dobson. The network helps show where Lee Dobson may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Dobson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2016 | 107 | |
| 7 | 2004 | 99 | |
| 8 | 2002 | 87 | |
| 9 | 2023 | 83 | |
| 10 | 2015 | 67 | |
| 11 | 2006 | 46 | |
| 12 | 2003 | 45 | |
| 13 | Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency? | 2004 | 30 |
| 14 | 2023 | 24 | |
| 15 | 2024 | 23 | |
| 16 | 2004 | 21 | |
| 17 | 2023 | 16 | |
| 18 | 2018 | 15 | |
| 19 | 2017 | 14 | |
| 20 | 2015 | 12 |
About Lee Dobson
Lee Dobson is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions, Infectious Diseases, Economics and Econometrics and Genetics, having authored 41 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (6 papers), Primary Care and Health Outcomes (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Occupational and environmental lung diseases (2 papers), Healthcare Policy and Management (2 papers), Pleural and Pulmonary Diseases (2 papers) and Quality and Management Systems (1 paper). The work is most often cited by research in Infectious Diseases (966 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (348 citations), Internal Medicine (56 citations) and Pulmonary and Respiratory Medicine (467 citations). Lee Dobson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Andrew Tym Hattersley, Christopher D. Sheldon, Daryl Paul Wilkerson, Paul Graham Winyard, Cathleen S Colon-Emeric, JAMES A. KELLY, Mark Gilchrist, Eleanor Schildwachter McConnell, Nigel Benjamin and Anthony I. Shepherd. Their work appears in journals such as The Lancet, International Journal of Technology Assessment in Health Care, Nitric Oxide, Frontiers in Physiology and British Journal of Educational Studies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.